TERT and thyroid gland carcinoma: Interestingly, concomitant BRAF V600E were observed in our HVPTC patient with TERT promoter mutation who died of disease during follow-up, which was consistent with the previous reports that coexistence of BRAF V600E and TERT represented the more aggressive biological behavior in thyroid cancer.